Kaya Ltd Share Price – NSE  /  BSE

Healthcare, Small Cap

Net Loss of Kaya reported to Rs 8.28 crore in the quarter ended December 2023 as against net loss of Rs 17.79 crore during the previous quarter ended December 2022. Sales rose 2.39% to Rs 102.39 crore in the quarter ended December 2023 as against Rs 100.00 crore during the previous quarter ended December 2022.

Powered by Capital Market - Live News

Kaya will hold a meeting of the Board of Directors of the Company on 30 January 2024.

Powered by Capital Market - Live News

Kaya announced that Kaya Middle East DMCC (DMCC), the material subsidiary of the Company has entered into definitive agreements to sell its entire holding in Minal Medical Centre LLC (MMC) and M M C Skin Clinic LLC (MMCSC), to Dr. Minal Patwardhan. The said transaction is completed.

Consequently MMC & MMCSC ceases to be the subsidiaries of DMCC.

Powered by Capital Market - Live News

Kaya announced that in view of the ongoing business reorganization in Gulf Cooperation Council region, Kaya Middle East FZE (FZE) has entered into a joint venture with Khimjis Ramdas LLC (Local partner), whereby FZE will hold 51% and Khimjis Ramdas LLC will hold 49% in Khimjis Health Care LLC (KHCLLC), in Oman.

Prior to the reorganization, FZE had economic and beneficial interest in KHCLLC.

Pursuant to the business reorganization in Gulf Cooperation Council region and to strengthen the equity structure, FZE has acquired 51% stake in KHCLLC.

FZE will hold 51% and Khimjis Ramdas LLC, Local partner, will hold the balance 49% of equity in KHCLLC.

Powered by Capital Market - Live News